Additional Trials Required

October 24, 2022

Tricida reaches the end of the road

September 26, 2022

Spectrum can’t catch a break

June 20, 2022

Focus turns to Rett as panel gives Acadia’s Nuplazid a thumbs down

May 13, 2022

UCB feels the pain of rejection

May 04, 2022

US FDA approval tracker: April 2022

May 03, 2022

China-backed US approvals continue to hang in the balance

April 27, 2022

A bad day for Molecular Partners

Setbacks hit two of the Swiss biotech’s clinical-stage darpin projects in a single day.

March 03, 2022

Karyopharm kicks the Xpovio can to an uncertain 2024

February 15, 2022

No end in sight for Larimar’s hold woes